Berenberg lowered the firm’s price target on GSK to 1,650 GBp from 1,730 GBp and keeps a Buy rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GSK:
- GlaxoSmithKline (GSK) Reveals Q1 Dividend: Here’s the Essential Information
- GSK price target raised to 1,400 GBp from 1,300 GBp at JPMorgan
- GSK price target lowered to 1,535 GBp from 1,610 GBp at Morgan Stanley
- CureVac announces progress in Phase 2 COVID-19, Seasonal Flu programs
- GSK raises FY23 adjusted EPS growth view to 17%-20% from 14%-17%